BIOMAT Database Logo BIOMAT Database Logo

Acute HIV-1 seroconversion with an unusual plasma biomarker profile. 2013

Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Department of Epidemiology, Fielding School of Public Health, University of California in Los Angeles, Los Angeles, California, USA.

An unusual case of acute primary HIV-1 infection in a man with a high plasma viral load, a 51-fold increase in C-reactive protein, and antibodies against only gp160 is described. Numerous serum cytokine concentrations were elevated during HIV-1 seroconversion.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Acute immunosuppression with HIV seroconversion.
January 1993, The New England journal of medicine,
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
An unusual seroconversion profile in a pregnant woman infected with the human immunodeficiency virus-1: need for using later generations HIV screening assays.
January 2008, Indian journal of medical microbiology,
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.
August 2006, Antiviral research,
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Autoimmune haemolytic anaemia: an unusual presentation of HIV seroconversion disease.
July 2010, AIDS (London, England),
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
A lupus-like glomerulonephritis following acute HIV-1 seroconversion in an African woman.
February 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples.
December 1997, Journal of virological methods,
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
April 1995, Annals of internal medicine,
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Acute HIV seroconversion and pneumonitis.
September 1991, AIDS (London, England),
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Seroconversion of acute hepatitis B by antiretroviral therapy in an HIV-1 infected patient.
January 2010, Acta gastro-enterologica Belgica,
Najib Aziz, and Roger Detels, and Otoniel Martinez-Maza, and John Oishi, and Beth D Jamieson, and Mallory D Witt, and Anthony W Butch
Acute ataxia coincident with seroconversion for anti-HIV.
September 1991, Journal of neurology,
Copied contents to your clipboard!